Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Current Topics in Behavioral Neurosciences|March 5, 2011
The impact of gender on antidepressantsJohn J Sramek, Neal R CutlerAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 15, 2003
Galantamine hydrobromide: an agent for Alzheimer's diseaseVictoria Zarotsky, John J Sramek, Neal R CutlerDrugs|July 12, 2002
Generalised anxiety disorder: treatment optionsJohn J Sramek, Victoria Zarotsky, Neal R CutlerContemporary Clinical Trials Communications|October 27, 2025
Establishing a clinical trial site: A primer for aspiring principal investigatorsJohn J Sramek, Modesto S Carrillo, Neal R CutlerDialogues in Clinical Neuroscience|February 10, 2017
Sex differences in the psychopharmacological treatment of depressionJohn J Sramek, Michael F Murphy, Neal R CutlerProgress in Neuro-Psychopharmacology & Biological Psychiatry|May 14, 2017
Lurasidone in post-menopausal females with major depressive disorder with mixed features: Post-hoc analysis of a placebo-controlled trialJohn Sramek, Antony Loebel, Michael Murphy, et al.Reviews on Recent Clinical Trials|February 10, 2021
Phase 1 Clinical Trials of Small Molecules: Evolution and State of the ArtJohn J Sramek, Michael F Murphy, Sherilyn Adcock, et al.Clinical Pharmacokinetics|April 4, 2002
Estimation of the absolute bioavailability of rivastigmine in patients with mild to moderate dementia of the Alzheimer's typeMohammad Hossain, Stanford S Jhee, Thomas Shiovitz, et al.Journal of Clinical Psychopharmacology|January 8, 2004
A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibitionEdmund P Harrigan, Jeffrey J Miceli, Richard Anziano, et al.Frontiers in Oncology|February 20, 2026
Advancements in intratumoral therapies for liver tumorsSteven S Raman, Neal R Cutler, John J Sramek, et al.Pageof 2